Fucoidan: Scientific Evidence for Anti-Inflammatory, Antiviral, and Cardiovascular Support

Fucoidan: Scientific Evidence for Anti-Inflammatory, Antiviral, and Cardiovascular Support

A scientific review published in Nutrition Reviews (Oxford Academic) highlights the diverse biological activities of fucoidan, a natural polysaccharide derived from brown seaweed, with strong potential in supporting immune health and disease prevention.

Key Findings of the Study

The research shows that fucoidan exhibits powerful anti-inflammatory effects by reducing pro-inflammatory cytokines such as IL-1β and IL-6—key drivers of chronic inflammation and related diseases.

In addition, fucoidan demonstrates antithrombotic properties, helping regulate blood clot formation through the stimulation of prostacyclin production. This mechanism plays an important role in supporting cardiovascular health and reducing the risk of vascular complications.

Notably, the study also highlights fucoidan’s antiviral potential, with in vitro evidence showing activity against multiple viruses, including influenza, hepatitis B, HIV, and even SARS-CoV-2.

Health Implications

These findings suggest that fucoidan may contribute to:

  • Reducing inflammation and protecting tissues
  • Supporting cardiovascular function and circulation
  • Enhancing antiviral defense mechanisms

Conclusion

This research reinforces fucoidan as a multi-functional bioactive compound with promising applications in dietary supplements and functional nutrition. Its combined anti-inflammatory, antiviral, and cardiovascular benefits make it a valuable ingredient for supporting overall health and long-term wellness.

Source:

Tamama, K. (2021). Potential benefits of dietary seaweeds as protection against COVID-19. Nutrition Reviews, 79(7), 814-823. https://doi.org/10.1093/nutrit/nuaa126

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.